ClinicalTrials.gg
Sign In

Panic Disorder clinical trials

The registry lists 270 studies for Panic Disorder across more than 10 countries. 37 are recruiting or about to start. 132 of them are mainly about Panic Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Panic Disorder studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
166
Status unknown
34
Recruiting
24
Terminated
20
Not yet recruiting
13
Active, not recruiting
11

Phase

Phase 4
32
Phase 2
27
Phase 3
20
Phase 1
12
Early Phase 1
1

Where

United States
109
Canada
21
Sweden
14
Germany
12
Turkey
9
United Kingdom
8

Who runs them

National Institute of Mental Health (NIMH) (9) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (7) · Karolinska Institutet (6) · Massachusetts General Hospital (6) · VA Office of Research and Development (5) · Universidade Federal do Rio de Janeiro (5) · Boston University Charles River Campus (4) · Laureate Institute for Brain Research, Inc. (4)

What is being tested here

Drugs under test in Panic Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Hydroxyzine101
Paroxetine019
Alprazolam007
Cycloserine015
Sertraline004
Escitalopram004
Quetiapine003
Risperidone003
Venlafaxine033
Caffeine002

Drug classes tested here SSRIs 17 · Antipsychotics 8 · Anxiolytics 8 · SNRIs 4 · Stimulants 3

Coming up

0phase 3 studies under way
15studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 24 Panic Disorder studies recruiting now, 8 (33%) set no upper age limit and 15 (63%) stop at 75 or younger. 6 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (13%) take healthy volunteers.

Recruiting studies that take each age, of 24
AgeWomenMen
105 (21%)5 (21%)
1818 (75%)18 (75%)
3018 (75%)18 (75%)
4018 (75%)18 (75%)
5018 (75%)18 (75%)
6517 (71%)17 (71%)
7510 (42%)10 (42%)
858 (33%)8 (33%)

Across all 270 studies, recruiting or not: 70% stop at 75 or younger and 62% at 65; 16% take children; 1% are for women only and 0% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Panic Disorder studies take

Of 87 interventional studies with no phase under Panic Disorder, half reached primary completion within 38 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase38 mo21–63 · 87 studies—38 mo21–63 · 87 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 270. Browse all 270 → or search them.